Literature DB >> 18330504

Increased activity of serotonin uptake in platelets in medication overuse headache following regular intake of analgesics and triptans.

Ilya Ayzenberg1, Mark Obermann, Mark Oberman, Kirsten Leineweber, Leonora Franke, Min-Suk Yoon, Hans-Christoph Diener, Zaza Katsarava.   

Abstract

We investigated the effect of chronic administration of different pain medications on the activity of the serotonin transporter (SERT) in patients with medication overuse headache (MOH). We measured the kinetic of platelet 5-HT uptake (maximal velocity, Vmax and the Michaelis-Menten constant, Km in patients with overuse of triptans (tMOH, n = 15) or analgesics (aMOH, n = 14) before and after drug withdrawal, as well as in headache-free healthy subjects (n = 15) and patients with episodic migraine (EM, n = 16). Vmax was increased similarly in both, tMOH and aMOH compared to healthy subjects and patients with EM and normalized after withdrawal in parallel to the improvement of headache frequency. Average Km was similar in all groups at baseline and not affected by the withdrawal. The data demonstrate a transient increase of SERT activity in patients with analgesic and triptan induced MOH but do not allow to differentiate whether the increase of serotonin uptake is caused by regular intake of analgesics or triptans or is a consequence of frequent headache attacks.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18330504      PMCID: PMC3476187          DOI: 10.1007/s10194-008-0019-9

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  18 in total

1.  Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats.

Authors:  U Reuter; S Salomone; G W Ickenstein; C Waeber
Journal:  Cephalalgia       Date:  2004-05       Impact factor: 6.292

2.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

3.  5HT in migraine patients with medication-induced headache.

Authors:  R Hering; V Glover; K Pattichis; T Catarci; T J Steiner
Journal:  Cephalalgia       Date:  1993-12       Impact factor: 6.292

4.  5-HT uptake in platelets of lithium-treated patients with affective disorders and of healthy controls.

Authors:  K Thies-Flechtner; I Weigel; B Müller-Oerlinghausen
Journal:  Pharmacopsychiatry       Date:  1994-07       Impact factor: 5.788

5.  Features of medication overuse headache following overuse of different acute headache drugs.

Authors:  V Limmroth; Z Katsarava; G Fritsche; S Przywara; H-C Diener
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

6.  Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache.

Authors:  A Srikiatkhachorn; N Tarasub; P Govitrapong
Journal:  Headache       Date:  2000-05       Impact factor: 5.887

7.  Medication use and disability among migraineurs: a national probability sample survey.

Authors:  D D Celentano; W F Stewart; R B Lipton; M L Reed
Journal:  Headache       Date:  1992-05       Impact factor: 5.887

Review 8.  The pharmacology of headache.

Authors:  P J Goadsby
Journal:  Prog Neurobiol       Date:  2000-12       Impact factor: 11.685

9.  Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain.

Authors:  C F Dobson; Y Tohyama; M Diksic; E Hamel
Journal:  Cephalalgia       Date:  2004-01       Impact factor: 6.292

Review 10.  The platelet and the neuron: two cells in focus in migraine.

Authors:  R Malmgren; L Hasselmark
Journal:  Cephalalgia       Date:  1988-03       Impact factor: 6.292

View more
  8 in total

Review 1.  Medication overuse headache.

Authors:  Valerie Cheung; Farnaz Amoozegar; Esma Dilli
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

Review 2.  Neurobiology of migraine progression.

Authors:  Wanakorn Rattanawong; Alan Rapoport; Anan Srikiatkhachorn
Journal:  Neurobiol Pain       Date:  2022-06-09

Review 3.  Future drugs for migraine.

Authors:  Ivano Farinelli; Sergio De Filippis; Gabriella Coloprisco; Serena Missori; Paolo Martelletti
Journal:  Intern Emerg Med       Date:  2009-06-24       Impact factor: 3.397

Review 4.  The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical Update.

Authors:  Christina Sun-Edelstein; Alan M Rapoport; Wanakorn Rattanawong; Anan Srikiatkhachorn
Journal:  CNS Drugs       Date:  2021-05-17       Impact factor: 5.749

5.  Abnormal cortical responses to somatosensory stimulation in medication-overuse headache.

Authors:  Gianluca Coppola; Antonio Currà; Cherubino Di Lorenzo; Vincenzo Parisi; Manuela Gorini; Simona Liliana Sava; Jean Schoenen; Francesco Pierelli
Journal:  BMC Neurol       Date:  2010-12-30       Impact factor: 2.474

Review 6.  Risk of medication overuse headache across classes of treatments for acute migraine.

Authors:  Kristian Thorlund; Christina Sun-Edelstein; Eric Druyts; Steve Kanters; Shanil Ebrahim; Rahul Bhambri; Elodie Ramos; Edward J Mills; Michel Lanteri-Minet; Stewart Tepper
Journal:  J Headache Pain       Date:  2016-11-24       Impact factor: 7.277

Review 7.  Chronic migraine: A process of dysmodulation and sensitization.

Authors:  Min Su; Shengyuan Yu
Journal:  Mol Pain       Date:  2018-04-12       Impact factor: 3.395

8.  Involvement of 5-Hydroxytryptamine Receptor 2A in the Pathophysiology of Medication-Overuse Headache.

Authors:  Zhenyang Zheng; Xiaolei Shi; Yue Xiang; Aiwu Zhang; Yannan Fang
Journal:  J Pain Res       Date:  2021-02-16       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.